The NIHR proactively supports the life sciences industry to develop new treatments, diagnostics and medical technologies at both early and late phases. The Life Sciences Industry section of our website outlines the services, expertise, facilities and resources that are available to help companies bring their research and development programmes to the UK and successfully deliver clinical trials and studies in NHS.
The NIHR Office for Clinical Research Infrastructure (NOCRI) provides a valuable resource for the global life sciences industry during early phase.
Visit the NOCRI section of this website to find out more.
The views of patients, carers and the public are important in shaping and developing future stroke research. Groups of patients and carers through the Patient Carer Public Involvement and Engagement (PCPIE) panels, provide a vital patient and carer perspective about stroke research, and advise us on how best to share information with patients.
The types of roles available include:
Patients and carers make a distinctive contribution to our work, offering their unique perspective and helping to shape the research.
Find out how to apply for Clinical Research Network support and how your study can benefit from our Study Support Service.
The Local Clinical Research Network (LCRN) teams can provide researchers and clinicians with practical guidance and support for successfully running studies in local areas. Please visit the NIHR in your area homepage to find your LCRN.
For more information on local opportunities contact your Local Clinical Research Network to get involved in their work, or in research studies that are running locally.
Patients are at the centre of our work. As a patient, carer or as a member of the public you can get involved by taking part in research, or by helping to shape research. There are several ways you can do this.
Taking part in research
If you are interested in participating in research you can:
To find out more please visit the NIHR Patients and the Public page.
Patient and public involvement in research
If you are interested in becoming involved in research visit the NIHR Patients and the Public page to find out more.
One third of patients have communication problems after a stroke, this is known as aphasia. NIHR Clinical Research Network Stroke has worked with people with aphasia and researchers to collate existing resources and develop new materials to help researchers to enable people with aphasia to participate in research.
The full resource pack is available here.
Good research ensures that the results are scientifically valid and that the participant’s safety is a priority. To bring this about, every trial follows a protocol (plan) that has been approved by an ethics committee to protect the interests of the participants. Before a trial can start, it must be reviewed by an NHS research governance working group, which offers independent advice on the quality of the proposed research.
Not every participant will receive the new treatment. If a trial is comparing a new treatment with an existing one, participants are randomly allocated to either treatment. This type of study is called a randomised controlled trial.
Placebos are often used in randomised controlled trials. A placebo is an inactive drug or treatment.
Each of our 15 Local Clinical Research Networks has at least one nominated local Clinical Specialty Research Lead for Stroke. These clinicians lead research groups to promote and support Stroke research within the NHS Trusts in their area.
At a national level the local leads come together to manage the national Stroke clinical research portfolio. This involves regularly reviewing the progress of studies, identifying barriers to recruitment, and coming up with solutions and strategies to help overcome those barriers. Our National Specialty Group of clinical experts offer advice and support to commercial and non-commercial customers looking to conduct research in the NHS.
Clinical research is being undertaken across the United Kingdom. We continue to work closely with the Scottish, Welsh and Northern Irish clinical research networks to support the design and delivery of high quality research.